Aligos Therapeutics
ALIGOS Therapeutics is dedicated to improving patient outcomes through best-in-class therapies for liver and viral diseases. The company focuses on science-driven approaches, leveraging expertise in medicinal chemistry and biology to develop differentiated pipeline therapies. Their mission is to create innovative treatments for unmet medical needs in hepatology and virology, with a vision to make a significant impact on patients worldwide.
Industries
Nr. of Employees
medium (51-250)
Aligos Therapeutics
1 Corporate Dr., 2nd Floor, South San Francisco, CA 94080
Patents
Products
Oral capsid assembly modulator for chronic hepatitis B
Preclinical and clinical-stage capsid assembly modulator program targeting hepatitis B virus designed to reduce viral markers via capsid modulation and related mechanisms.
Oral thyroid hormone receptor beta (THR-β) agonist for steatohepatitis
Selective THR-β agonist program focused on modulating hepatic metabolism to address metabolic dysfunction-associated steatohepatitis (MASH/NASH).
Oral capsid assembly modulator for chronic hepatitis B
Preclinical and clinical-stage capsid assembly modulator program targeting hepatitis B virus designed to reduce viral markers via capsid modulation and related mechanisms.
Oral thyroid hormone receptor beta (THR-β) agonist for steatohepatitis
Selective THR-β agonist program focused on modulating hepatic metabolism to address metabolic dysfunction-associated steatohepatitis (MASH/NASH).
Services
Partnerships and collaborative research engagements for discovery and preclinical development of liver and antiviral therapeutics; business development contact provided for inquiries.
Partnerships and collaborative research engagements for discovery and preclinical development of liver and antiviral therapeutics; business development contact provided for inquiries.
Expertise Areas
- Antiviral drug discovery
- Liver disease therapeutics (HBV, MASH/NASH)
- Small-molecule medicinal chemistry
- Oligonucleotide therapeutics
Key Technologies
- Small-molecule medicinal chemistry
- Oligonucleotide design and synthesis
- Nucleoside chemistry
- Cell-based hepatocyte assays
News & Updates
Company Achieves Milestone in HBV Treatment
ALIGOS Therapeutics announced a significant milestone in the development of its HBV therapy pipeline.
Innovative Therapies for Liver Diseases
ALIGOS Therapeutics is pioneering new treatments for liver and viral diseases, aiming to improve patient outcomes.
Pipeline Development Award
Recognized for advancing a differentiated pipeline of therapies for hepatology and virology.
Company Achieves Milestone in HBV Treatment
ALIGOS Therapeutics announced a significant milestone in the development of its HBV therapy pipeline.
Innovative Therapies for Liver Diseases
ALIGOS Therapeutics is pioneering new treatments for liver and viral diseases, aiming to improve patient outcomes.
Pipeline Development Award
Recognized for advancing a differentiated pipeline of therapies for hepatology and virology.